New York subpoenas Amgen's sales, marketing documents
Healthcare Auditing Weekly, June 5, 2007
Amgen Inc. received a subpoena last week from the New York state attorney general, who is seeking documents related to its sales and marketing activities.
Amgen said it received the subpoena May 10, according to a Securities and Exchange Commission filing in which it also said it intended to cooperate with the attorney general.
The day of the subpoena, Amgen was dealt a setback by an advisory panel of cancer experts for the Food and Drug Administration. The group recommended that new restrictions be placed on prescribing Amgen's top-selling anemia treatments, Aranesp and Epogen, after studies showed that high doses of the drugs could raise the risks of heart attack, stroke and death.
A week later, Medicare said it would stop paying for the drugs for a number of unapproved uses. The new restrictions on the drugs could cause sales of Amgen's anemia drugs to drop by a fifth this year, analysts have said.
Source: Bloomberg News
Related Products
-
Strategies for Health Care Compliance
News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...
-
Compliance Monitor
This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...
-
Medicare Weekly Update
Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...
-
Medicare Update for Physician Services
Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- HIPAA Q&A: Level of encryption needed for email
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- QA:Coding multiple initial infusions
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HIPAA Q&A: Level of encryption needed for email
- Q&A: Follow CMS' coding guidelines when using modifier -25
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- CMS has reformulated payments for some bilateral procedures
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- ED-to-inpatient transfers are flawed with safety gaps
- Searched